Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)
Clinical trial NCT02723955 · COMPLETED
Trial details
- NCT number
- NCT02723955
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-23
- Primary completion
- 2023-07-05
- Enrollment
- 829
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.